Terug
Dagbereik
€ 3,05
€ 3,23
52-Weeksbereik
€ 1,11
€ 5,47
Volume
5.144.758
50D / 200D Gem.
€ 4,17
/
€ 3,40
Vorige Slotkoers
€ 3,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,5 | 0,4 |
| P/B | 24,4 | 2,9 |
| ROE % | -160,8 | 3,9 |
| Net Margin % | -3216,2 | 3,8 |
| Rev Growth 5Y % | -40,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 6,00
+91.7%
Forward WPA
-€ 0,18
Omzet Sch.
99 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,63
€ 0,49 – € 0,77
|
450 M | 1 |
| FY2028 |
€ 0,38
€ 0,30 – € 0,47
|
330 M | 1 |
| FY2027 |
€ 0,07
-€ 0,01 – € 0,16
|
210 M | 2 |
Belangrijkste Punten
Revenue declined -40,82% annually over 5 years
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -76,76M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,87%
Capital intensive — 218,70% of revenue goes to capex
Groei
Revenue Growth (5Y)
-40,82%
Revenue (1Y)-36,95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-160,80%
ROIC-230,08%
Net Margin-3216,18%
Op. Margin-3440,23%
Veiligheid
Debt / Equity
0,14
Current Ratio4,76
Interest Coverage-22504,83
Waardering
P/E Ratio
-7,45
P/B Ratio24,42
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -36,95% | Revenue Growth (3Y) | -61,81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -40,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,93M | Net Income (TTM) | -126,24M |
| ROE | -160,80% | ROA | -86,90% |
| Gross Margin | -8,71% | Operating Margin | -3440,23% |
| Net Margin | -3216,18% | Free Cash Flow (TTM) | -76,76M |
| ROIC | -230,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 4,76 |
| Interest Coverage | -22504,83 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,45 | P/B Ratio | 24,42 |
| P/S Ratio | 239,58 | PEG Ratio | -0,12 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 940,34M | Enterprise Value | 916,33M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 3,93M | 6,23M | 26,91M | 14,27M | 31,99M |
| Net Income | -126,24M | -95,90M | 28,32M | -92,17M | -170,52M |
| EPS (Diluted) | -0,47 | -0,39 | -0,33 | -0,47 | -1,02 |
| Gross Profit | -342.000,0 | 106.000,0 | 20,57M | -39,41M | -12,81M |
| Operating Income | -135,03M | -99,76M | -75,73M | -91,95M | -86,32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 145,27M | 151,04M | 215,98M | 359,86M | 314,59M |
| Total Liabilities | 106,75M | 32,55M | 89,72M | 252,51M | 247,41M |
| Shareholders' Equity | 38,51M | 118,50M | 126,26M | 107,35M | 67,17M |
| Total Debt | 5,50M | 7,10M | 51,42M | 190,07M | 182,28M |
| Cash & Equivalents | 29,52M | 7,58M | 4,86M | 36,42M | 51,79M |
| Current Assets | 102,41M | 68,76M | 118,16M | 156,63M | 148,95M |
| Current Liabilities | 21,52M | 22,99M | 78,65M | 34,65M | 42,13M |